Allergy

The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement

February 28, 2021

Article

In data presented during AAAAI 21, researchers compared the 2006 and 2016 versions of the diagnostic criteria proposed by the NIAD/FAAN.

Dupilumab for Eosinophilic Esophagitis

February 28, 2021

Video

Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.

Sublingual Immunotherapy May Provide Peanut Allergy Desensitization in Toddlers

February 28, 2021

Article

Late-breaking data show allegic children as young as 1-4 years old may have sustained benefit from daily peanut protein exposure.

Early Peanut Introduction Decreases Rates of Peanut Allergies

February 28, 2021

Article

The adjusted allergy prevalence in recent years was 2.6% in infants who have been introduced to peanuts at 12 months.

Asthma Users Weight Positives, Negatives for Cannabis Use

February 27, 2021

Article

Common positive effects includes help with sleep, less pain, and calming influence.

PALFORZIA at 3 Years: New Data Show Sustained Peanut Immunotherapy Benefit, Safety

February 27, 2021

Video

A discussion on continued research into the first regulated treatment for pediatric peanut allergy.

How DBV Intends to Assess its Peanut Immunotherapy Patch Long-term

January 28, 2021

Video

Pending FDA decision, the Viaskin Peanut patch would be considered for lengthier benefit studies.

Pharis Mohideen, MD, MS: Updates on the Viaskin Peanut Patch

January 25, 2021

Video

The epicutaneous immunotherapy for peanut allergy is continuing discussions with the FDA. What is its potential in allergic care?

CDC Issues Anaphylaxis Report on Moderna Vaccine First Dose

January 22, 2021

Article

In the initial report, investigators find just 2.5 cases of anaphylaxis per million doses of the Moderna COVID-19 vaccine.

Flu Shot Protocol May Help Efforts to Improve COVID-19 Vaccination

January 21, 2021

Article

An individualized model that provides vaccine-hesitant patients resources without compromising autonomy could aid efforts to limit the pandemic with new vaccines.